or their salts where R1 and R2 mean independently hydrogen, halogen atom, trifluoromethyl-group, C1-C6-alkyl or C1-C6-alkoxy-group; Y means groups or =CH where underlined atom takes part in cyclic system; X means groups -O-, -S-, -CR7R8-, -CH2-CH2-, -CH= CH--CH2-, -CH2-CH= CH-, -CH2CH2CH2-, -CH= CH-, -NR9-(C=O)-, -O-CH2-, -(C=O)- or -(S=O)- where R7, R8, R9 mean independently hydrogen atom or C1-C6-alkyl; r = 1, 2 or 3; M = 1 or 2; n = 1 when m = 1 and n = 0 when m = 2; R4 and R5 each means hydrogen atom or when m = 2 then both in common can form a bond; R6 is hydroxyl or C1-C8-alkoxy-group, or its pharmaceutically acceptable salt under condition that compounds 10-[3-(3-carbomethoxy-1-piperidyl)-propyl} -phenothiazine and 10-[3-(3-carbohexoxy-1-piperidyl)-propyl] -phenothiazine are not included. Compounds of the formula (I) inhibit neurogenic inflammation and can be used in medicine. Invention describes also method of synthesis of compounds of the formula (I), pharmaceutical composition and method of inhibition of neurogenic inflammation. EFFECT: improved method of synthesis, valuable medicinal properties. 9 cl, 2 tbl, 18 ex"/>
N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION OF NEUROGENIC INFLAMMATION
首页>
外国专利>
N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION OF NEUROGENIC INFLAMMATION
N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION OF NEUROGENIC INFLAMMATION
FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel N-substituted azaheterocyclic carboxylic acid of the formula (I) or their salts where R1 and R2 mean independently hydrogen, halogen atom, trifluoromethyl-group, C1-C6-alkyl or C1-C6-alkoxy-group; Y means groups or =CH where underlined atom takes part in cyclic system; X means groups -O-, -S-, -CR7R8-, -CH2-CH2-, -CH= CH--CH2-, -CH2-CH= CH-, -CH2CH2CH2-, -CH= CH-, -NR9-(C=O)-, -O-CH2-, -(C=O)- or -(S=O)- where R7, R8, R9 mean independently hydrogen atom or C1-C6-alkyl; r = 1, 2 or 3; M = 1 or 2; n = 1 when m = 1 and n = 0 when m = 2; R4 and R5 each means hydrogen atom or when m = 2 then both in common can form a bond; R6 is hydroxyl or C1-C8-alkoxy-group, or its pharmaceutically acceptable salt under condition that compounds 10-[3-(3-carbomethoxy-1-piperidyl)-propyl} -phenothiazine and 10-[3-(3-carbohexoxy-1-piperidyl)-propyl] -phenothiazine are not included. Compounds of the formula (I) inhibit neurogenic inflammation and can be used in medicine. Invention describes also method of synthesis of compounds of the formula (I), pharmaceutical composition and method of inhibition of neurogenic inflammation. EFFECT: improved method of synthesis, valuable medicinal properties. 9 cl, 2 tbl, 18 ex
展开▼